http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006512353-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 2003-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006512353-A |
| titleOfInvention | Oxazolidinone derivatives as antibacterial agents |
| abstract | Formula (I) wherein C is selected from D and E, and R 2 a, R 6 a and R 3 a in Formula (D), Formula (E) are independently selected from, for example, H, CF 3 , Me and Et; R 2 b and R 6 b are independently selected from, for example, H, F, CF 3 , Me and Et; R 1 b is, for example, acetamide; R 4 is, for example, an optionally substituted 5- or 6-membered heterocyclic ring system, or a pharmaceutically acceptable salt or in-vivo hydrolysable ester thereof. Also described are methods of making the compounds of formula (I), compositions containing them, and their use as antimicrobial agents. |
| priorityDate | 2002-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 357.